S4S8-RPA phosphorylation as an indicator of cancer progression in oral squamous cell carcinomas

Jeff Rector, Sasha Kapil, Kelly J. Treude, Phyllis Kumm, Jason G. Glanzer, Brendan M. Byrne, Shengqin Liu, Lynette M Smith, Dominick J DiMaio, Peter J Giannini, Russell B. Smith, Gregory G Oakley

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Oral cancers are easily accessible compared to many other cancers. Nevertheless, oral cancer is often diagnosed late, resulting in a poor prognosis. Most oral cancers are squamous cell carcinomas that predominantly develop from cell hyperplasias and dysplasias. DNA damage is induced in these tissues directly or indirectly in response to oncogene-induced deregulation of cellular proliferation. Consequently, a DNA Damage response (DDR) and a cell cycle checkpoint is activated. As dysplasia transitions to cancer, proteins involved in DNA damage and checkpoint signaling are mutated or silenced decreasing cell death while increasing genomic instability and allowing continued tumor progression. Hyperphosphorylation of Replication Protein A (RPA), including phosphorylation of Ser4 and Ser8 of RPA2, is a well-known indicator of DNA damage and checkpoint activation. In this study, we utilize S4S8-RPA phosphorylation as a marker for cancer development and progression in oral squamous cell carcinomas (OSCC). S4S8-RPA phosphorylation was observed to be low in normal cells, high in dysplasias, moderate in early grade tumors, and low in late stage tumors, essentially supporting the model of the DDR as an early barrier to tumorigenesis in certain types of cancers. In contrast, overall RPA expression was not correlative to DDR activation or tumor progression. Utilizing S4S8-RPA phosphorylation to indicate competent DDR activation in the future may have clinical significance in OSCC treatment decisions, by predicting the susceptibility of cancer cells to first-line platinum-based therapies for locally advanced, metastatic and recurrent OSCC.

Original languageEnglish (US)
Pages (from-to)9243-9250
Number of pages8
JournalOncotarget
Volume8
Issue number6
DOIs
StatePublished - Jan 1 2017

Fingerprint

Replication Protein A
Squamous Cell Carcinoma
Phosphorylation
DNA Damage
Neoplasms
Mouth Neoplasms
Genomic Instability
Cell Cycle Checkpoints
Platinum
Oncogenes
Hyperplasia
Carcinogenesis
Cell Death
Cell Proliferation

Keywords

  • Immunohistochemistry
  • Phosphorylation
  • Replication protein A
  • Squamous cell carcinoma
  • Tumorigenicity

ASJC Scopus subject areas

  • Oncology

Cite this

S4S8-RPA phosphorylation as an indicator of cancer progression in oral squamous cell carcinomas. / Rector, Jeff; Kapil, Sasha; Treude, Kelly J.; Kumm, Phyllis; Glanzer, Jason G.; Byrne, Brendan M.; Liu, Shengqin; Smith, Lynette M; DiMaio, Dominick J; Giannini, Peter J; Smith, Russell B.; Oakley, Gregory G.

In: Oncotarget, Vol. 8, No. 6, 01.01.2017, p. 9243-9250.

Research output: Contribution to journalArticle

Rector, Jeff ; Kapil, Sasha ; Treude, Kelly J. ; Kumm, Phyllis ; Glanzer, Jason G. ; Byrne, Brendan M. ; Liu, Shengqin ; Smith, Lynette M ; DiMaio, Dominick J ; Giannini, Peter J ; Smith, Russell B. ; Oakley, Gregory G. / S4S8-RPA phosphorylation as an indicator of cancer progression in oral squamous cell carcinomas. In: Oncotarget. 2017 ; Vol. 8, No. 6. pp. 9243-9250.
@article{f74c5a02806f482986809b5a0760535f,
title = "S4S8-RPA phosphorylation as an indicator of cancer progression in oral squamous cell carcinomas",
abstract = "Oral cancers are easily accessible compared to many other cancers. Nevertheless, oral cancer is often diagnosed late, resulting in a poor prognosis. Most oral cancers are squamous cell carcinomas that predominantly develop from cell hyperplasias and dysplasias. DNA damage is induced in these tissues directly or indirectly in response to oncogene-induced deregulation of cellular proliferation. Consequently, a DNA Damage response (DDR) and a cell cycle checkpoint is activated. As dysplasia transitions to cancer, proteins involved in DNA damage and checkpoint signaling are mutated or silenced decreasing cell death while increasing genomic instability and allowing continued tumor progression. Hyperphosphorylation of Replication Protein A (RPA), including phosphorylation of Ser4 and Ser8 of RPA2, is a well-known indicator of DNA damage and checkpoint activation. In this study, we utilize S4S8-RPA phosphorylation as a marker for cancer development and progression in oral squamous cell carcinomas (OSCC). S4S8-RPA phosphorylation was observed to be low in normal cells, high in dysplasias, moderate in early grade tumors, and low in late stage tumors, essentially supporting the model of the DDR as an early barrier to tumorigenesis in certain types of cancers. In contrast, overall RPA expression was not correlative to DDR activation or tumor progression. Utilizing S4S8-RPA phosphorylation to indicate competent DDR activation in the future may have clinical significance in OSCC treatment decisions, by predicting the susceptibility of cancer cells to first-line platinum-based therapies for locally advanced, metastatic and recurrent OSCC.",
keywords = "Immunohistochemistry, Phosphorylation, Replication protein A, Squamous cell carcinoma, Tumorigenicity",
author = "Jeff Rector and Sasha Kapil and Treude, {Kelly J.} and Phyllis Kumm and Glanzer, {Jason G.} and Byrne, {Brendan M.} and Shengqin Liu and Smith, {Lynette M} and DiMaio, {Dominick J} and Giannini, {Peter J} and Smith, {Russell B.} and Oakley, {Gregory G}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.14001",
language = "English (US)",
volume = "8",
pages = "9243--9250",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "6",

}

TY - JOUR

T1 - S4S8-RPA phosphorylation as an indicator of cancer progression in oral squamous cell carcinomas

AU - Rector, Jeff

AU - Kapil, Sasha

AU - Treude, Kelly J.

AU - Kumm, Phyllis

AU - Glanzer, Jason G.

AU - Byrne, Brendan M.

AU - Liu, Shengqin

AU - Smith, Lynette M

AU - DiMaio, Dominick J

AU - Giannini, Peter J

AU - Smith, Russell B.

AU - Oakley, Gregory G

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Oral cancers are easily accessible compared to many other cancers. Nevertheless, oral cancer is often diagnosed late, resulting in a poor prognosis. Most oral cancers are squamous cell carcinomas that predominantly develop from cell hyperplasias and dysplasias. DNA damage is induced in these tissues directly or indirectly in response to oncogene-induced deregulation of cellular proliferation. Consequently, a DNA Damage response (DDR) and a cell cycle checkpoint is activated. As dysplasia transitions to cancer, proteins involved in DNA damage and checkpoint signaling are mutated or silenced decreasing cell death while increasing genomic instability and allowing continued tumor progression. Hyperphosphorylation of Replication Protein A (RPA), including phosphorylation of Ser4 and Ser8 of RPA2, is a well-known indicator of DNA damage and checkpoint activation. In this study, we utilize S4S8-RPA phosphorylation as a marker for cancer development and progression in oral squamous cell carcinomas (OSCC). S4S8-RPA phosphorylation was observed to be low in normal cells, high in dysplasias, moderate in early grade tumors, and low in late stage tumors, essentially supporting the model of the DDR as an early barrier to tumorigenesis in certain types of cancers. In contrast, overall RPA expression was not correlative to DDR activation or tumor progression. Utilizing S4S8-RPA phosphorylation to indicate competent DDR activation in the future may have clinical significance in OSCC treatment decisions, by predicting the susceptibility of cancer cells to first-line platinum-based therapies for locally advanced, metastatic and recurrent OSCC.

AB - Oral cancers are easily accessible compared to many other cancers. Nevertheless, oral cancer is often diagnosed late, resulting in a poor prognosis. Most oral cancers are squamous cell carcinomas that predominantly develop from cell hyperplasias and dysplasias. DNA damage is induced in these tissues directly or indirectly in response to oncogene-induced deregulation of cellular proliferation. Consequently, a DNA Damage response (DDR) and a cell cycle checkpoint is activated. As dysplasia transitions to cancer, proteins involved in DNA damage and checkpoint signaling are mutated or silenced decreasing cell death while increasing genomic instability and allowing continued tumor progression. Hyperphosphorylation of Replication Protein A (RPA), including phosphorylation of Ser4 and Ser8 of RPA2, is a well-known indicator of DNA damage and checkpoint activation. In this study, we utilize S4S8-RPA phosphorylation as a marker for cancer development and progression in oral squamous cell carcinomas (OSCC). S4S8-RPA phosphorylation was observed to be low in normal cells, high in dysplasias, moderate in early grade tumors, and low in late stage tumors, essentially supporting the model of the DDR as an early barrier to tumorigenesis in certain types of cancers. In contrast, overall RPA expression was not correlative to DDR activation or tumor progression. Utilizing S4S8-RPA phosphorylation to indicate competent DDR activation in the future may have clinical significance in OSCC treatment decisions, by predicting the susceptibility of cancer cells to first-line platinum-based therapies for locally advanced, metastatic and recurrent OSCC.

KW - Immunohistochemistry

KW - Phosphorylation

KW - Replication protein A

KW - Squamous cell carcinoma

KW - Tumorigenicity

UR - http://www.scopus.com/inward/record.url?scp=85011964393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011964393&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.14001

DO - 10.18632/oncotarget.14001

M3 - Article

C2 - 27999209

AN - SCOPUS:85011964393

VL - 8

SP - 9243

EP - 9250

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 6

ER -